PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Esophageal cancer is one of the most common malignant tumors, and the 5-year overall survival rate is only 20%. Esophageal squamous cell carcinoma (ESCC) is the primary histological type of esophageal carcinoma in China. Protein phosphatase 1 regulatory subunit 18 (PPP1r18) is one of the actin-regulatory proteins and is able to bind to protein phosphatase 1 catalytic subunit alpha (PPP1CA). Yet, little is known about the role of PPP1r18 in esophageal squamous cell carcinoma (ESCC). This study aimed to elucidate the biological functions of PPP1r18 in the ESCC progression. Clinical samples first confirmed that PPP1r18 expression was upregulated in ESCC, and PPP1r18 was correlated with tumor invasion depth, lymph node metastasis, distant metastasis, and reduced overall survival. We then observed that PPP1r18 overexpression enhanced cell proliferation in vitro and in vivo. Mechanistically, PPP1r18 regulated tumor progression of ESCC through activating the calcineurin-mediated ERK pathway, rather than binding to PPP1CA. Collectively, our results suggest that PPP1r18 promotes ESCC progression by regulating the calcineurin-mediated ERK pathway. PPP1r18 might be a potential target for the diagnosis and treatment of ESCC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Xie, W., Sun, Y., Zeng, Y., Hu, L., Zhi, J., Ling, H. H., Zheng, X., Ruan, X., & Gao, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.2012316 · Cited by 30
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,524
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
The MAPK signalling pathways and colorectal cancer
Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
Griffith, J. P., Kim, J. L., Kim, E. E., Sintchak, M. D., Thomson, J. A., Fitzgibbon, M. J., Fleming, M. A., Caron, P. R., Hsiao, K., & Navia, M. A. (1995) · Cell · doi:10.1016/0092-8674(95)90439-5 · Cited by 834
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
RAF-MEK-ERK pathway in cancer evolution and treatment
Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553
MOLKENTIN, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.021 · Cited by 497
Apoptosome: a platform for the activation of initiator caspases
Bao, Q., & Shi, Y. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402028 · Cited by 466
Li, H.-H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422220 · Cited by 430
THE MANY ROLES OF c-Myc IN APOPTOSIS
Thompson, E. B. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.575 · Cited by 328
Opposing roles for calcineurin and ATF3 in squamous skin cancer
Wu, X., Nguyen, B.-C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer, G. F. L., & Dotto, G. P. (2010) · Nature · doi:10.1038/nature08996 · Cited by 292
Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis
Wang, L., Li, K., Lin, X., Yao, Z., Wang, S., Xiong, X., Ning, Z., Wang, J., Xu, X., Jiang, Y., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.014 · Cited by 226
Creamer, T. P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00636-4 · Cited by 170
Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis
Garcia, A., Cayla, X., Guergnon, J., Dessauge, F., Hospital, V., Rebollo, M. P., Fleischer, A., & Rebollo, A. (2003) · Biochimie · doi:10.1016/j.biochi.2003.09.004 · Cited by 164
Donaldson, C., Eder, S., Baker, C., Aronovitz, M. J., Weiss, A. D., Hall-Porter, M., Wang, F., Ackerman, A., Karas, R. H., Molkentin, J. D., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190397 · Cited by 148
Sun, H., Ou, B., Zhao, S., Liu, X., Song, L., Liu, X., Wang, R., & Peng, Z. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.061 · Cited by 146
KSR2 Is a Calcineurin Substrate that Promotes ERK Cascade Activation in Response to Calcium Signals
Dougherty, M. K., Ritt, D. A., Zhou, M., Specht, S. I., Monson, D. M., Veenstra, T. D., & Morrison, D. K. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.001 · Cited by 129
Luo, Q., Wu, X., Zhao, P., Nan, Y., Chang, W., Zhu, X., Su, D., & Liu, Z. (2021) · Advanced Science · doi:10.1002/advs.202002874 · Cited by 105
Phosphatases in Mitosis: Roles and Regulation
Moura, M., & Conde, C. (2019) · Biomolecules · doi:10.3390/biom9020055 · Cited by 101
Xiao, L., Gong, L., Yuan, D., Deng, M., Zeng, X.-M., Chen, L.-L., Zhang, L., Yan, Q., Liu, J.-P., Hu, X.-H., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.16 · Cited by 98
Luo, Y., Jiang, N., May, H. I., Luo, X., Ferdous, A., Schiattarella, G. G., Chen, G., Li, Q., Li, C., Rothermel, B. A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052384 · Cited by 88
Peuker, K., Strigli, A., Tauriello, D. V. F., Hendricks, A., Schönfels, W. V., Burmeister, G., Brosch, M., Herrmann, A., Krüger, S., Nitsche, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.008 · Cited by 72
Mishra, A., Oulès, B., Pisco, A. O., Ly, T., Liakath-Ali, K., Walko, G., Viswanathan, P., Tihy, M., Nijjher, J., Dunn, S.-J., et al. (2017) · eLife · doi:10.7554/elife.27356 · Cited by 69
Wu, J.-G., Wang, J.-J., Jiang, X., Lan, J., He, X., Wang, H., Ma, Y., Xia, Y., Ru, G., Ma, J., et al. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0421-8 · Cited by 67
Targeting Myc-driven stress addiction in colorectal cancer
Saeed, H., Leibowitz, B. J., Zhang, L., & Yu, J. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100963 · Cited by 61
ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth
Zuo, Z., Liu, J., Sun, Z., Cheng, Y., Ewing, M., Bugge, T. H., Finkel, T., Leppla, S. H., & Liu, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211927120 · Cited by 58
Identification of phostensin, a PP1 F-actin cytoskeleton targeting subunit
Kao, S.-C., Chen, C.-Y., Wang, S.-L., Yang, J., Hung, W.-C., Chen, Y., Lai, N., Liu, H.-T., Huang, H.-L., Chen, H., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.026 · Cited by 37
Zhao, X., Huang, L., Lu, Y., Jiang, W., Song, Y., Qiu, B., Tao, D., Liu, Y., & Ma, Y. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00725-4 · Cited by 36
Dotto, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3750 · Cited by 34
Ferrer, I., Verdugo‐Sivianes, E. M., Castilla, M. Á., Melendez, R., Marín, J., Muñoz-Galván, S., Guerra, J. L. L., Vieites, B., Ortiz-Gordillo, M. J., León, J. M. D., et al. (2015) · Oncogene · doi:10.1038/onc.2015.341 · Cited by 34
Matos, B., Howl, J., Jerónimo, C., & Fardilha, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.001 · Cited by 32
Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Figueiredo, J. P., Silva, O. A. B. D. C. E., & Fardilha, M. (2014) · Current Cancer Drug Targets · doi:10.2174/15680096113136660106 · Cited by 30
Matsubara, T., Kokabu, S., Nakatomi, C., Kinbara, M., Maeda, T., Yoshizawa, M., Yasuda, H., Takano-Yamamoto, T., Baron, R., & Jimi, E. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00425-17 · Cited by 28
Phostensin caps to the pointed end of actin filaments and modulates actin dynamics
Lai, N., Wang, T.-F., Wang, S.-L., Chen, C.-Y., Yen, J.-Y., Huang, H.-L., Li, C., Huang, K.-Y., Liu, S.-Q., Lin, T.-H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.086 · Cited by 25
Su, Y., Zhang, T., Lu, J., Qian, L., Fei, Y., Zhang, L., Fan, S., Zhou, J., Tang, J., Chen, H., et al. (2023) · Cells · doi:10.3390/cells12010180 · Cited by 20
Wang, Y., Liu, S., Chen, Y., Zhu, B., & Xing, Q. (2022) · World Journal of Oncology · doi:10.14740/wjon1446 · Cited by 17
Yang, X., Li, G., Xue, Q., Luo, Y., Wang, S., Xia, Y., Zhuang, L., & Yu, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-13975-z · Cited by 14
Identification and Characterization of the Actin-Binding Motif of Phostensin
Wang, T.-F., Lai, N., Huang, K.-Y., Huang, H.-L., Lu, M., Lin, Y.-S., Chen, C.-Y., Liu, S.-Q., Liu, S.-Q., & Huang, H.-B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131215967 · Cited by 11
Identification of the High Molecular Weight Isoform of Phostensin
Lin, Y.-S., Huang, H.-L., Liu, W., Liu, W., & Huang, H.-B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011068 · Cited by 8
Cited by
Jin, C., Lu, L., Gao, J., & Chen, L. (2024) · Current Molecular Medicine · doi:10.2174/0115665240312877241010123403 · Cited by 2
Schallen, K. P., Schomacker, K. T., Banila, C., Pink, H., Dest, N., & Coleman, K. L. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-56604-4 · Cited by 2
Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04266-7
“Based on existing literature, we hypothesize that PPP1R18 may function as a scaffold protein to facilitate Src-mediated activation of the ERK pathway, given that PPP1R18 is a known binding partner of Src, a classic upstream activator of the Ras/Raf/MEK/ERK cascade [18, 21, 38–40].”
InfluentialLiu, X., Zhang, S., Wu, Z., Zhang, M., Ju, Q., Tang, X., Chen, Y., & Sun, C. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.09.001
Self-citationBiogenic magnetic nanoparticles as regulators of mechanosensitive calcium signaling in tumors
Salatskyi, Y., Gorobets, S., & Gorobets, O. (2026) · Regulatory Mechanisms in Biosystems · doi:10.15421/0226164
Metadata
- Authors
- Ren, C., Wu, L., Zhang, S., Qi, K., Zhang, Y., Xu, J., Ruan, Y., & Feng, M.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Corresponding author
- Ruan, Yuanyuan
- Feng, Mingxiang
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-05-08
- Volume
- 45
- Issue
- 9
- Pages
- 673-684
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W4396726142
- Cited by
- 5
- References
- 49
- Citations by year
- 2026: 4 · 2024: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Technology Commission of Shanghai Municipality (20Y11908200)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- esophageal squamous cell carcinoma, calcineurin, ERK signaling, tumor progression, tumor invasion, lymph node metastasis, distant metastasis, cell proliferation, PPP1CA, prognostic factors, therapeutic target
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Animals, Cell Movement, Esophageal Neoplasms, Female, Humans, Lymphatic Metastasis, Male, Mice, Nude, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Disease Progression, Calcineurin, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Cell Proliferation, Mice, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.